Other authors reported that the beneficial effect of Qtn on glucose metabolism involves a downregulation of SREBP-1c in adipocytes [139], hepatocytes [140] and diabetic rats [141], or affected by NAFLD [142,143]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.